Symbols / NEOG Stock $9.40 +4.33% Neogen Corporation

Healthcare • Medical Devices • United States • NMS
NEOG (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Mikhael Nassif
Exch · Country NMS · United States
Market Cap 2.05B
Enterprise Value 2.68B
Income -608.84M
Sales 870.56M
FCF (ttm) 19.47M
Book/sh 9.66
Cash/sh 0.73
Employees 2,974
Insider 10d —
IPO Aug 23, 1989
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 31.69
PEG 0.66
P/S 2.35
P/B 0.97
P/C —
EV/EBITDA 33.00
EV/Sales 3.08
Quick Ratio 1.97
Current Ratio 3.92
Debt/Eq 37.82
LT Debt/Eq —
EPS (ttm) -2.80
EPS next Y 0.30
EPS Growth —
Revenue Growth -4.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-04-09
Earnings (prior) 2026-04-09
ROA -0.61%
ROE -25.57%
ROIC —
Gross Margin 45.21%
Oper. Margin -1.56%
Profit Margin -69.94%
Shs Outstand 217.67M
Shs Float 216.51M
Insider Own 0.94%
Instit Own 106.80%
Short Float 6.16%
Short Ratio 3.57
Short Interest 10.03M
52W High 11.43
vs 52W High -17.76%
52W Low 4.53
vs 52W Low 107.51%
Beta 1.97
Impl. Vol. 59.18%
Rel Volume 0.52
Avg Volume 2.81M
Volume 1.48M
Target (mean) $12.00
Tgt Median $12.00
Tgt Low $11.00
Tgt High $13.00
# Analysts 3
Recom Buy
Prev Close $9.01
Price $9.40
Change 4.33%
About

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals. This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$12.00
Mean price target
2. Current target
$9.40
Latest analyst target
3. DCF / Fair value
$1.61
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$9.40
Low
$11.00
High
$13.00
Mean
$12.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-12 reit Piper Sandler Neutral → Neutral $10
2026-01-09 main Guggenheim Buy → Buy $12
2025-12-10 up CJS Securities Market Perform → Market Outperform $10
2025-10-16 reit Piper Sandler Neutral → Neutral $7
2025-09-29 init CJS Securities — → Market Perform $10
2025-07-29 down William Blair Outperform → Market Perform —
2025-06-30 main Guggenheim Buy → Buy $10
2025-04-22 main Piper Sandler Neutral → Neutral $5
2025-04-14 main Piper Sandler Neutral → Neutral $7
2025-04-10 main Guggenheim Buy → Buy $13
2025-01-21 reit Piper Sandler Neutral → Neutral $13
2024-12-19 init Guggenheim — → Buy $15
2024-08-06 main Piper Sandler Neutral → Neutral $18
2024-04-15 main Piper Sandler Neutral → Neutral $17
2024-01-18 main Piper Sandler Neutral → Neutral $19
2023-10-16 main Piper Sandler Neutral → Neutral $18
2023-08-14 main Wells Fargo Overweight → Overweight $28
2023-06-16 init Wells Fargo — → Overweight $22
2022-12-15 main Piper Sandler — → Neutral $17
2022-11-22 up William Blair Market Perform → Outperform —
News
RSS: Latest NEOG news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-17 NASSIF MIKHEAL Chief Executive Officer — 23 $10.94 $252
2026-02-02 NASSIF MIKHEAL Chief Executive Officer — 49 $9.86 $486
2026-01-16 NASSIF MIKHEAL Chief Executive Officer — 137 $9.33 $1,279
2026-01-07 RANALLI TAMARA A Officer — 50,813 $7.38 $375,000
2026-01-07 RANALLI TAMARA A Officer — 101,626 $7.38 $750,000
2025-12-01 NAEMURA DAVID HARTMAN Former — 12,912 $5.98 $77,214
2025-11-03 RIGGSBEE RICHARD BRYAN Chief Financial Officer — 178,855 $6.29 $1,124,998
2025-11-03 NASSIF MIKHEAL Chief Executive Officer — 177 $6.25 $1,106
2025-10-27 BOREL JAMES C. Director — 2,025 $6.19 $12,535
2025-10-27 BOREL JAMES C. Director — 1,777 $6.19 $11,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Total Revenue
894.66
-3.20%
924.22
+12.37%
822.45
+56.01%
527.16
Operating Revenue
894.66
-3.20%
924.22
+12.37%
822.45
+56.01%
527.16
Cost Of Revenue
473.29
+2.82%
460.32
+10.52%
416.49
+46.58%
284.15
Reconciled Cost Of Revenue
473.29
+2.82%
460.32
+10.52%
416.49
+46.58%
284.15
Gross Profit
421.38
-9.17%
463.90
+14.27%
405.95
+67.05%
243.01
Operating Expense
423.05
+4.40%
405.24
+9.99%
368.44
+99.81%
184.40
Research And Development
21.09
-6.18%
22.48
-13.68%
26.04
+52.73%
17.05
Selling General And Administration
401.96
+5.02%
382.76
+11.79%
342.40
+104.61%
167.35
Selling And Marketing Expense
183.80
+0.51%
182.87
+29.49%
141.22
+66.92%
84.60
General And Administrative Expense
218.17
+9.14%
199.89
-0.64%
201.18
+143.14%
82.74
Other Gand A
218.17
+9.14%
199.89
-0.64%
201.18
+143.14%
82.74
Total Expenses
896.34
+3.56%
865.56
+10.27%
784.93
+67.53%
468.54
Operating Income
-1.68
-102.86%
58.66
+56.37%
37.52
-36.00%
58.62
Total Operating Income As Reported
-1,061.00
-1908.63%
58.66
+56.37%
37.52
-36.00%
58.62
EBITDA
-935.82
-618.99%
180.32
+44.96%
124.39
+47.37%
84.41
Normalized EBITDA
123.50
-31.51%
180.32
+44.96%
124.39
+47.37%
84.41
Reconciled Depreciation
125.67
+3.67%
121.23
+33.99%
90.47
+274.91%
24.13
EBIT
-1,061.49
-1896.42%
59.09
+74.21%
33.92
-43.73%
60.28
Total Unusual Items
-1,059.32
0.00
0.00
—
Total Unusual Items Excluding Goodwill
-1,059.32
0.00
0.00
—
Special Income Charges
-1,059.32
0.00
0.00
—
Impairment Of Capital Assets
1,059.32
0.00
0.00
—
Net Income
-1,092.04
-11491.59%
-9.42
+58.81%
-22.87
-147.34%
48.31
Pretax Income
-1,133.11
-7821.08%
-14.30
+35.10%
-22.04
-136.61%
60.21
Net Non Operating Interest Income Expense
-68.51
-2.21%
-67.03
-26.97%
-52.80
-4266.93%
1.27
Interest Expense Non Operating
71.62
-2.41%
73.39
+31.15%
55.96
+77623.61%
0.07
Net Interest Income
-68.51
-2.21%
-67.03
-26.97%
-52.80
-4266.93%
1.27
Interest Expense
71.62
-2.41%
73.39
+31.15%
55.96
+77623.61%
0.07
Interest Income Non Operating
3.11
-51.12%
6.36
+100.95%
3.17
+136.45%
1.34
Interest Income
3.11
-51.12%
6.36
+100.95%
3.17
+136.45%
1.34
Other Income Expense
-3.60
+39.34%
-5.94
+12.22%
-6.76
-2200.00%
0.32
Other Non Operating Income Expenses
1,055.72
+17885.04%
-5.94
+12.22%
-6.76
-2200.00%
0.32
Tax Provision
-41.07
-740.83%
-4.88
-689.86%
0.83
-93.04%
11.90
Tax Rate For Calcs
0.00
-89.38%
0.00
+62.58%
0.00
+6.25%
0.00
Tax Effect Of Unusual Items
-38.39
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-1,092.04
-11491.59%
-9.42
+58.81%
-22.87
-147.34%
48.31
Net Income From Continuing Operation Net Minority Interest
-1,092.04
-11491.59%
-9.42
+58.81%
-22.87
-147.34%
48.31
Net Income From Continuing And Discontinued Operation
-1,092.04
-11491.59%
-9.42
+58.81%
-22.87
-147.34%
48.31
Net Income Continuous Operations
-1,092.04
-11491.59%
-9.42
+58.81%
-22.87
-147.34%
48.31
Normalized Income
-71.11
-654.85%
-9.42
+58.81%
-22.87
-147.34%
48.31
Net Income Common Stockholders
-1,092.04
-11491.59%
-9.42
+58.81%
-22.87
-147.34%
48.31
Diluted EPS
-5.03
-11465.35%
-0.04
+63.76%
-0.12
-126.78%
0.45
Basic EPS
-5.03
-11465.35%
-0.04
+58.88%
-0.11
-123.60%
0.45
Basic Average Shares
216.89
+0.13%
216.61
+0.17%
216.25
+100.60%
107.80
Diluted Average Shares
216.89
+0.13%
216.61
+0.17%
216.25
+100.19%
108.02
Diluted NI Availto Com Stockholders
-1,092.04
-11491.59%
-9.42
+58.81%
-22.87
-147.34%
48.31
Line Item Trend 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Total Assets
3,443.84
-24.29%
4,548.83
-0.12%
4,554.43
+358.69%
992.93
Current Assets
576.94
-2.09%
589.23
+0.56%
585.93
-6.52%
626.80
Cash Cash Equivalents And Short Term Investments
129.00
-24.53%
170.94
-30.39%
245.57
-35.55%
381.05
Cash And Cash Equivalents
129.00
-24.39%
170.61
+4.52%
163.24
+267.05%
44.47
Other Short Term Investments
0.00
-100.00%
0.33
-99.61%
82.33
-75.54%
336.58
Receivables
153.38
-11.34%
173.00
+12.89%
153.25
+53.75%
99.67
Accounts Receivable
153.38
-11.34%
173.00
+12.89%
153.25
+53.75%
99.67
Gross Accounts Receivable
158.78
-10.37%
177.15
+13.50%
156.08
+54.04%
101.32
Allowance For Doubtful Accounts Receivable
-5.40
-30.36%
-4.14
-46.44%
-2.83
-71.33%
-1.65
Inventory
190.86
+0.84%
189.27
+41.44%
133.81
+9.40%
122.31
Raw Materials
65.69
-16.63%
78.80
+18.29%
66.62
+13.55%
58.67
Work In Process
11.23
+2.21%
10.99
+104.81%
5.37
-16.00%
6.39
Finished Goods
130.42
+16.61%
111.84
+64.23%
68.10
+18.93%
57.26
Prepaid Assets
—
—
—
23.76
Assets Held For Sale Current
50.40
0.00
—
—
Other Current Assets
53.29
-4.89%
56.02
+5.12%
53.30
+124.31%
23.76
Total Non Current Assets
2,866.90
-27.60%
3,959.60
-0.22%
3,968.50
+983.90%
366.13
Net PPE
356.28
+22.06%
291.89
+38.54%
210.68
+85.19%
113.77
Gross PPE
511.71
+18.40%
432.18
+30.65%
330.80
+51.30%
218.64
Accumulated Depreciation
-155.43
-10.79%
-140.29
-16.79%
-120.12
-14.53%
-104.88
Properties
0.00
0.00
0.00
0.00
Land And Improvements
10.82
+3.04%
10.50
+2.82%
10.21
+7.63%
9.48
Buildings And Improvements
108.72
+0.39%
108.30
+11.89%
96.79
+21.73%
79.51
Machinery Furniture Equipment
188.78
+2.25%
184.63
+15.66%
159.63
+32.48%
120.49
Construction In Progress
186.24
+63.42%
113.97
+118.17%
52.24
+774.41%
5.97
Other Properties
17.15
+16.01%
14.79
+23.90%
11.93
+274.78%
3.18
Goodwill And Other Intangible Assets
2,475.39
-32.13%
3,647.28
-2.55%
3,742.60
+1395.80%
250.21
Goodwill
1,064.90
-50.14%
2,135.63
-0.09%
2,137.50
+1397.85%
142.70
Other Intangible Assets
1,410.48
-6.69%
1,511.65
-5.82%
1,605.10
+1393.08%
107.50
Other Non Current Assets
35.23
+72.47%
20.43
+34.20%
15.22
+605.94%
2.16
Total Liabilities Net Minority Interest
1,372.58
-2.29%
1,404.69
-1.09%
1,420.21
+1245.47%
105.56
Current Liabilities
174.01
+12.76%
154.32
+6.08%
145.47
+86.88%
77.84
Payables And Accrued Expenses
96.28
-7.86%
104.50
+10.26%
94.77
+54.70%
61.26
Payables
85.20
-8.88%
93.51
+11.83%
83.62
+127.60%
36.74
Accounts Payable
79.61
-4.16%
83.06
+8.34%
76.67
+121.50%
34.61
Current Accrued Expenses
11.08
+0.85%
10.98
-1.47%
11.15
-54.53%
24.52
Pensionand Other Post Retirement Benefit Plans Current
14.13
-29.15%
19.95
-20.69%
25.15
+126.14%
11.12
Total Tax Payable
5.60
-46.42%
10.45
+50.32%
6.95
+226.95%
2.13
Income Tax Payable
5.60
-46.42%
10.45
+50.32%
6.95
+226.95%
2.13
Current Debt And Capital Lease Obligation
19.30
+688.76%
2.45
—
—
Current Debt
19.30
+688.76%
2.45
—
—
Current Capital Lease Obligation
—
2.45
0.00
—
Current Deferred Liabilities
5.56
+19.99%
4.63
+0.35%
4.62
-15.46%
5.46
Current Deferred Revenue
5.56
+19.99%
4.63
+0.35%
4.62
-15.46%
5.46
Other Current Liabilities
38.74
+69.89%
22.80
+8.91%
20.93
—
Total Non Current Liabilities Net Minority Interest
1,198.57
-4.14%
1,250.37
-1.91%
1,274.74
+4500.13%
27.71
Long Term Debt And Capital Lease Obligation
874.81
-1.53%
888.39
+0.33%
885.44
—
Long Term Debt
874.81
-1.53%
888.39
+0.33%
885.44
—
Long Term Capital Lease Obligation
—
0.00
—
—
Non Current Deferred Liabilities
280.91
-14.02%
326.72
-7.56%
353.43
+1977.64%
17.01
Non Current Deferred Taxes Liabilities
280.91
-14.02%
326.72
-7.56%
353.43
+1977.64%
17.01
Other Non Current Liabilities
42.85
+21.54%
35.26
-1.72%
35.88
+235.30%
10.70
Stockholders Equity
2,071.25
-34.12%
3,144.14
+0.32%
3,134.22
+253.20%
887.37
Common Stock Equity
2,071.25
-34.12%
3,144.14
+0.32%
3,134.22
+253.20%
887.37
Capital Stock
34.73
+0.20%
34.66
+0.17%
34.60
+100.60%
17.25
Common Stock
34.73
+0.20%
34.66
+0.17%
34.60
+100.60%
17.25
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
217.04
+0.20%
216.61
+0.17%
216.25
+100.60%
107.80
Ordinary Shares Number
217.04
+0.20%
216.61
+0.17%
216.25
+100.60%
107.80
Additional Paid In Capital
2,601.85
+0.70%
2,583.89
+0.63%
2,567.83
+728.37%
309.98
Retained Earnings
-536.42
-196.55%
555.62
-1.67%
565.04
-3.89%
587.91
Gains Losses Not Affecting Retained Earnings
-28.90
+3.74%
-30.02
+9.71%
-33.25
-19.74%
-27.77
Other Equity Adjustments
-28.90
+3.74%
-30.02
+9.71%
-33.25
-19.74%
-27.77
Total Equity Gross Minority Interest
2,071.25
-34.12%
3,144.14
+0.32%
3,134.22
+253.20%
887.37
Total Capitalization
2,946.06
-26.94%
4,032.53
+0.32%
4,019.66
+352.98%
887.37
Working Capital
402.93
-7.35%
434.91
-1.26%
440.46
-19.76%
548.95
Invested Capital
2,965.36
-26.51%
4,034.98
+0.38%
4,019.66
+352.98%
887.37
Total Debt
894.11
+0.37%
890.84
+0.61%
885.44
—
Net Debt
765.11
+6.23%
720.23
-0.27%
722.20
—
Capital Lease Obligations
—
0.00
0.00
—
Net Tangible Assets
-404.13
+19.68%
-503.14
+17.30%
-608.38
-195.48%
637.17
Tangible Book Value
-404.13
+19.68%
-503.14
+17.30%
-608.38
-195.48%
637.17
Interest Payable
11.08
+0.85%
10.98
-1.47%
11.15
0.00
Inventories Adjustments Allowances
-16.48
-33.35%
-12.36
-97.15%
-6.27
—
Line Item Trend 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Operating Cash Flow
58.24
+65.17%
35.26
-14.05%
41.03
-39.70%
68.04
Cash Flow From Continuing Operating Activities
58.24
+65.17%
35.26
-14.05%
41.03
-39.70%
68.04
Net Income From Continuing Operations
-1,092.04
-11491.59%
-9.42
+58.81%
-22.87
-147.34%
48.31
Depreciation Amortization Depletion
125.67
+3.67%
121.23
+33.99%
90.47
+274.91%
24.13
Depreciation
125.67
+3.67%
121.23
+33.99%
90.47
+274.91%
24.13
Depreciation And Amortization
125.67
+3.67%
121.23
+33.99%
90.47
+274.91%
24.13
Other Non Cash Items
0.38
-95.64%
8.72
+21.83%
7.16
+393.56%
-2.44
Stock Based Compensation
17.29
+25.59%
13.77
+35.29%
10.18
+42.26%
7.15
Asset Impairment Charge
1,068.75
0.00
0.00
0.00
Deferred Tax
-57.78
-110.71%
-27.42
-42.61%
-19.23
-309.58%
-4.70
Deferred Income Tax
-57.78
-110.71%
-27.42
-42.61%
-19.23
-309.58%
-4.70
Operating Gains Losses
1.91
+78.29%
1.07
+320.78%
-0.49
—
Gain Loss On Sale Of PPE
-0.03
-102.33%
1.07
+320.78%
-0.49
0.00
Change In Working Capital
-5.93
+91.84%
-72.68
-200.38%
-24.20
-447.32%
-4.42
Change In Receivables
11.64
+157.90%
-20.10
+62.69%
-53.88
-590.93%
-7.80
Changes In Account Receivables
11.64
+157.90%
-20.10
+62.69%
-53.88
-590.93%
-7.80
Change In Inventory
-16.12
+71.19%
-55.95
-662.02%
9.96
+147.24%
-21.07
Change In Prepaid Assets
-1.50
-113.53%
11.11
+456.07%
-3.12
+23.01%
-4.05
Change In Payables And Accrued Expense
-0.31
-102.27%
13.59
-40.13%
22.69
+12.14%
20.24
Change In Accrued Expense
0.09
+156.71%
-0.16
-104.05%
4.05
0.00
Change In Payable
-0.40
-102.92%
13.75
-26.24%
18.64
-7.89%
20.24
Change In Account Payable
-0.40
-102.92%
13.75
-26.24%
18.64
-7.89%
20.24
Change In Other Working Capital
0.36
+101.69%
-21.33
-13952.60%
0.15
-98.14%
8.27
Investing Cash Flow
-99.19
-238.45%
-29.31
-114.58%
201.04
+306.77%
-97.23
Cash Flow From Continuing Investing Activities
-99.19
-238.45%
-29.31
-114.58%
201.04
+306.77%
-97.23
Net PPE Purchase And Sale
-99.52
+10.59%
-111.31
-71.43%
-64.93
-165.79%
-24.43
Purchase Of PPE
-104.59
+6.13%
-111.42
-69.44%
-65.76
-169.18%
-24.43
Sale Of PPE
5.08
+4599.07%
0.11
-86.92%
0.83
0.00
Capital Expenditure
-104.59
+6.13%
-111.42
-69.44%
-65.76
-169.18%
-24.43
Net Investment Purchase And Sale
0.33
-99.60%
82.00
-67.75%
254.25
+846.58%
-34.05
Purchase Of Investment
0.00
0.00
+100.00%
-12.52
+96.99%
-415.89
Sale Of Investment
0.33
-99.60%
82.00
-69.26%
266.77
-30.13%
381.84
Net Business Purchase And Sale
0.00
0.00
-100.00%
11.72
+130.25%
-38.74
Purchase Of Business
—
—
—
-38.74
Financing Cash Flow
-1.60
-183.32%
1.92
+101.62%
-118.08
-1833.17%
6.81
Cash Flow From Continuing Financing Activities
-1.60
-183.32%
1.92
+101.62%
-118.08
-1833.17%
6.81
Net Issuance Payments Of Debt
-0.32
+23.57%
-0.42
+99.58%
-100.00
0.00
Issuance Of Debt
550.00
0.00
0.00
—
Repayment Of Debt
-550.32
-130928.81%
-0.42
+99.58%
-100.00
0.00
Long Term Debt Issuance
550.00
0.00
0.00
—
Long Term Debt Payments
-550.32
-130928.81%
-0.42
+99.58%
-100.00
0.00
Net Long Term Debt Issuance
-0.32
+23.57%
-0.42
+99.58%
-100.00
0.00
Net Common Stock Issuance
—
—
—
—
Common Stock Payments
—
—
—
—
Repurchase Of Capital Stock
—
—
—
—
Proceeds From Stock Option Exercised
2.24
-8.71%
2.46
+105.52%
1.20
-84.94%
7.93
Net Other Financing Charges
-3.52
-2882.20%
-0.12
+99.39%
-19.28
-1621.07%
-1.12
Changes In Cash
-42.55
-640.44%
7.87
-93.65%
123.99
+654.05%
-22.38
Effect Of Exchange Rate Changes
0.94
+287.65%
-0.50
+90.38%
-5.22
+40.36%
-8.75
Beginning Cash Position
170.61
+4.52%
163.24
+267.05%
44.47
-41.17%
75.60
End Cash Position
129.00
-24.39%
170.61
+4.52%
163.24
+267.05%
44.47
Free Cash Flow
-46.35
+39.14%
-76.16
-207.97%
-24.73
-156.71%
43.61
Interest Paid Supplemental Data
68.14
-6.87%
73.17
+71.69%
42.62
+59088.89%
0.07
Income Tax Paid Supplemental Data
26.54
+19.02%
22.30
+44.14%
15.47
-10.26%
17.24
Change In Interest Payable
0.09
+156.71%
-0.16
-104.05%
4.05
0.00
Sale Of Business
0.00
0.00
-100.00%
11.72
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category